Suppr超能文献

Apelin是血管紧张素II介导的不良心肌重塑和功能障碍的负调节因子。

Apelin Is a Negative Regulator of Angiotensin II-Mediated Adverse Myocardial Remodeling and Dysfunction.

作者信息

Zhang Zhen-Zhou, Wang Wang, Jin Hai-Yan, Chen Xueyi, Cheng Yu-Wen, Xu Ying-Le, Song Bei, Penninger Josef M, Oudit Gavin Y, Zhong Jiu-Chang

机构信息

From the State Key Laboratory of Medical Genomics and Shanghai Institute of Hypertension (Z.-Z.Z., Y.-W.C., Y.-L.X., B.S., J.-C.Z.) and Department of Mental Health (H.-Y.J.), Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, China; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, China (Z.-Z.Z., J.-C.Z.); Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute (W.W., X.C., G.Y.O.) and Department of Physiology (W.W., X.C., G.Y.O.), University of Alberta, Edmonton, Canada; and Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria (J.M.P.).

出版信息

Hypertension. 2017 Dec;70(6):1165-1175. doi: 10.1161/HYPERTENSIONAHA.117.10156. Epub 2017 Oct 3.

Abstract

The apelin pathway has emerged as a critical regulator of cardiovascular homeostasis and disease. However, the exact role of pyr1-apelin-13 in angiotensin (Ang) II-mediated heart disease remains unclear. We used apelin-deficient (APLN) and apolipoprotein E knockout mice to evaluate the regulatory roles of pyr1-apelin-13. The 1-year aged APLN mice developed myocardial hypertrophy and dysfunction with reduced angiotensin-converting enzyme 2 levels. Ang II infusion (1.5 mg kg d) for 4 weeks potentiated oxidative stress, pathological hypertrophy, and myocardial fibrosis in young APLN hearts resulting in exacerbation of cardiac dysfunction. Importantly, daily administration of 100 μg/kg pyr1-apelin-13 resulted in upregulated angiotensin-converting enzyme 2 levels, decreased superoxide production and expression of hypertrophy- and fibrosis-related genes leading to attenuated myocardial hypertrophy, fibrosis, and dysfunction in the Ang II-infused apolipoprotein E knockout mice. In addition, pyr1-apelin-13 treatment largely attenuated Ang II-induced apoptosis and ultrastructural injury in the apolipoprotein E knockout mice by activating Akt and endothelial nitric oxide synthase phosphorylation signaling. In cultured neonatal rat cardiomyocytes and cardiofibroblasts, exposure of Ang II decreased angiotensin-converting enzyme 2 protein and increased superoxide generation, cellular proliferation, and migration, which were rescued by pyr1-apelin-13, and Akt and endothelial nitric oxide synthase agonist stimulation. The increased superoxide generation and apoptosis in cultured cardiofibroblasts in response to Ang II were strikingly prevented by pyr1-apelin-13 which was partially reversed by cotreatment with the Akt inhibitor MK2206. In conclusion, pyr1-apelin-13 peptide pathway is a negative regulator of aging-mediated and Ang II-mediated adverse myocardial remodeling and dysfunction and represents a potential candidate to prevent and treat heart disease.

摘要

阿片肽通路已成为心血管稳态和疾病的关键调节因子。然而,pyr1-阿片肽-13在血管紧张素(Ang)II介导的心脏病中的确切作用仍不清楚。我们使用阿片肽缺陷(APLN)和载脂蛋白E基因敲除小鼠来评估pyr1-阿片肽-13的调节作用。1岁龄的APLN小鼠出现心肌肥大和功能障碍,同时血管紧张素转换酶2水平降低。对年轻的APLN心脏进行4周的Ang II输注(1.5 mg·kg-1·d-1)会增强氧化应激、病理性肥大和心肌纤维化,导致心脏功能障碍加重。重要的是,每日给予100 μg/kg的pyr1-阿片肽-13可使血管紧张素转换酶2水平上调,并减少超氧化物生成以及肥大和纤维化相关基因的表达,从而减轻Ang II输注的载脂蛋白E基因敲除小鼠的心肌肥大、纤维化和功能障碍。此外,pyr1-阿片肽-13治疗通过激活Akt和内皮型一氧化氮合酶磷酸化信号,在很大程度上减轻了Ang II诱导的载脂蛋白E基因敲除小鼠的细胞凋亡和超微结构损伤。在培养的新生大鼠心肌细胞和成纤维细胞中,Ang II暴露会降低血管紧张素转换酶2蛋白水平,并增加超氧化物生成、细胞增殖和迁移,而pyr1-阿片肽-13以及Akt和内皮型一氧化氮合酶激动剂刺激可使其恢复。pyr1-阿片肽-13可显著预防Ang II诱导的培养成纤维细胞中超氧化物生成增加和细胞凋亡,而与Akt抑制剂MK2206共同处理可部分逆转这种作用。总之,pyr1-阿片肽-13肽通路是衰老介导和Ang II介导的不良心肌重塑及功能障碍的负调节因子,是预防和治疗心脏病的潜在候选物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验